• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 88 of 100
571977919
HealthGlobal Drug Spending Will Reach $1.4 Trillion by 2020
By Laura LorenzettiNovember 18, 2015
Police Operation in Saint Denis
TechParis Siege and Square Prices IPO–5 Things to Know Today
By Laura Lorenzetti and Geoffrey SmithNovember 18, 2015
Flibanserin
HealthWhy ‘Female Viagra’ Is Not Selling
By Robert HackettNovember 17, 2015
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
FinanceWhy Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
LeadershipMylan, Valeant and Theranos: What the Heck, Biotech?
By Jeffrey SonnenfeldNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
HealthMylan’s Hostile Bid for Perrigo Fails
By ReutersNovember 13, 2015
Bill Ackman
HealthValeant, Ackman Must Face U.S. Insider Trading Lawsuit
By ReutersNovember 11, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant CEO Defends Firm but Says He Doesn’t Have ‘Full Knowledge’
By Stephen GandelNovember 10, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
HealthAstrazeneca is Buying ZS Pharma for $2.7 billion
By Laura LorenzettiNovember 6, 2015
Walgreens-Rite Aid deal could lead to elimination of 3,000 stores
RetailWalgreens-Rite Aid deal could lead to elimination of 3,000 stores
By Phil WahbaNovember 5, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring Says it Will Lower Daraprim Price by the End of the Year
By Laura LorenzettiNovember 4, 2015
Fortune Global Forum 2015
HealthHow the U.S. Subsidizes Europe’s Health Care Costs
By Beth KowittNovember 3, 2015
Hedge fund manager Bill Ackman
FinanceBill Ackman on Valeant: ‘Life will go on’
By Stephen GandelOctober 30, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthValeant cuts ties to controversial pharmacy chain Philidor
By Geoffrey SmithOctober 30, 2015
Hedge fund manager Bill Ackman
FinanceAnother one of Bill Ackman’s top stocks is down 50%
By Jen WiecznerOctober 29, 2015
1...
  • 86
  • 87
  • 88
  • 89
  • 90
...100
Most Popular
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and countingplaceholder alt text
By Jacqueline MunisJune 24, 2026
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Retail
Amazon's record Prime Day masks a darker truth: Americans are spending more and getting lessplaceholder alt text
By Nick LichtenbergJune 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.